We are live on ! Find out more
IBB icon

iShares Biotechnology ETF
IBB

894 hedge funds and large institutions have $5.28B invested in iShares Biotechnology ETF in 2024 Q2 according to their latest regulatory filings, with 78 funds opening new positions, 201 increasing their positions, 333 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 65

1.36% more ownership

Funds ownership: 69.54% → 70.9% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 11 → 11 (0)

1% less funds holding

Funds holding: 899 → 894 (-5)

1% less capital invested

Capital invested by funds: $5.32B → $5.28B (-$36.1M)

40% less repeat investments, than reductions

Existing positions increased: 201 | Existing positions reduced: 333

76% less call options, than puts

Call options by funds: $301M | Put options by funds: $1.27B

Holders
894
Holders Change
-5
Holders Change %
-0.56%
% of All Funds
12.91%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
78
Increased
201
Reduced
333
Closed
65
Calls
$301M
Puts
$1.27B
Net Calls
-$972M
Net Calls Change
-$125M

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$117M
2
Citigroup
Citigroup
New York
+$67M
3
JP Morgan Chase
JP Morgan Chase
New York
+$53.3M
4
Citadel Advisors
Citadel Advisors
Florida
+$29.1M
5
Two Sigma Investments
Two Sigma Investments
New York
+$15.5M

Top Sellers

Rank Fund Capital Flow
1
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$89M
2
UBS Group
UBS Group
Switzerland
-$70.8M
3
Millennium Management
Millennium Management
New York
-$38.6M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$28.6M
5
Bank Julius Baer & Co
Bank Julius Baer & Co
Switzerland
-$23.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
AWM
876
Angeles Wealth Management
California
$3.29K +$3.2K +24 New
FIA
877
FPC Investment Advisory
California
$2.93K – – –
SIS
878
Sound Income Strategies
Florida
$2.47K – – –
RS
879
Rakuten Securities
Japan
$2.06K -$7.74K -58 -79%
RWMG
880
Redwood Wealth Management Group
New Jersey
$2.06K +$2K +15 New
CB
881
CNB Bank
Pennsylvania
$1.78K – – –
BL
882
Balentine LLC
Georgia
$1.65K – – –
CSWM
883
Cassady Schiller Wealth Management
Ohio
$1.65K – – –
PA
884
PSI Advisors
Florida
$1.65K – – –
AF
885
Aviso Financial
Ontario, Canada
$1.65K +$1.6K +12 New
PIM
886
Progressive Investment Management
Oregon
$1.51K – – –
BGA
887
Battery Global Advisors
Massachusetts
$1.38K +$4.27K +32 New
LCM
888
Logan Capital Management
Pennsylvania
$1.38K – – –
GI
889
Gradient Investments
Minnesota
$1.24K -$133 -1 -10%
FCMT
890
Founders Capital Management (Texas)
Texas
$835 – – –
CPBTD
891
Central Pacific Bank - Trust Division
Hawaii
$686 – – –
AWM
892
Aspire Wealth Management
Massachusetts
$555 – – –
WPWM
893
Western Pacific Wealth Management
Illinois
$413 – – –
Parallax Volatility Advisers
894
Parallax Volatility Advisers
California
$412 – – –
ANBT
895
American National Bank & Trust
Texas
$412 +$400 +3 New
MCM
896
Manchester Capital Management
Vermont
$138 +$133 +1 New
OLVIG
897
Oliver Lagore Vanvalin Investment Group
Michigan
$64 – – –
CP
898
Camelot Portfolios
Ohio
$4 – – –
GAA
899
Global Assets Advisory
Florida
– -$3.52M -481,413 Closed
Squarepoint
900
Squarepoint
New York
– -$15.6M -116,534 Closed
34 35
36
37 38

IBB Hedge Fund Activity: Q2 2024 in Review

894 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in iShares Biotechnology ETF (IBB) for Q2 2024, worth a combined $5.28B — down 0.68% from $5.32B a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new IBB positions and 65 closed out — a net gain of 13 holders — while 201 added to existing stakes and 333 trimmed.

The largest buyer was Jane Street, adding an estimated $117M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $89M.

  • 894 institutional investors held iShares Biotechnology ETF (IBB) as of Q2 2024, down from 899 in Q1 2024.
  • Funds reported $5.28B of iShares Biotechnology ETF stock for Q2 2024, down 0.68% quarter-over-quarter.
  • 78 funds opened new iShares Biotechnology ETF positions in Q2 2024 and 65 closed out, a net change of +13 holders.
  • The largest iShares Biotechnology ETF buyer in Q2 2024 was Jane Street, an estimated $117M added.
  • The largest iShares Biotechnology ETF seller in Q2 2024 was Thrivent Financial for Lutherans, an estimated $89M sold.

Based on aggregated 13F filings for Q2 2024.